ENTERA BIO LTD

Entera Bio CEO’s RSU grant boosts insider confidence and signals optimism for phase‑3 trials, potentially lifting stock toward its 52‑week high.

Insider buying fuels optimism for Entera Bio as Germano Geno acquires 20,000 shares, signaling confidence in the company’s growth potential.

Insider buying at Entera Bio signals management confidence amid mixed market sentiment – could spur a rebound if key milestones materialize.